资讯

The stage is set for hopefuls in the grassroots levels as well as coaches in their respective sports this summer.
Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...
Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...
Discover some of the most valuable hockey cards featuring legends like Gretzky and McDavid. Find out which rare gems are ...
This compares with the PSA test, in which 25 per cent of men with a high PSA level will actually have prostate cancer. Of these 187 men, 118 (63.1 per cent) had a PSA level below 3.0ug/L, which is ...
whereas only 25% of those with elevated PSA levels received a cancer diagnosis. The non-invasive nature of the saliva test allows for at-home sample collection, potentially increasing ...
Baseline PSA level was significantly higher for the ARSI doublet group: 262.5 vs 170.1 ng/mL. Among ARSI doublet therapy recipients, 201 achieved a PSA nadir of 0.02 ng/mL or less, whereas 162 had ...
Of the 187 men, 118 had a PSA level below 3.0ug/L - which is considered "normal" and would typically indicate no further screening is required. Writing in the New England Journal of Medicine ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
Prostate cancer was detected in 187 men and, of these, 103 had cancer that was deemed to be “higher risk”, so treatment was offered. Of the 187 men, 118 had a PSA level below 3.0ug/L – which is ...
Of the 187 men, 118 had a PSA level below 3.0ug/L – which is considered “normal” and would usually indicate that no further screening is required. Writing in the New England Journal of ...
and The Royal Marsden NHS Foundation Trust conducted tests of the new spit test and found it to be more effective at detecting prostate cancer in men with low PSA levels than traditional testing.